• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物统计学系列模块9:生存分析。

Biostatistics Series Module 9: Survival Analysis.

作者信息

Hazra Avijit, Gogtay Nithya

机构信息

Department of Pharmacology, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India.

Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.

出版信息

Indian J Dermatol. 2017 May-Jun;62(3):251-257. doi: 10.4103/ijd.IJD_201_17.

DOI:10.4103/ijd.IJD_201_17
PMID:28584366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5448258/
Abstract

Survival analysis is concerned with "time to event" data. Conventionally, it dealt with cancer death as the event in question, but it can handle any event occurring over a time frame, and this need not be always adverse in nature. When the outcome of a study is the time to an event, it is often not possible to wait until the event in question has happened to all the subjects, for example, until all are dead. In addition, subjects may leave the study prematurely. Such situations lead to what is called censored observations as complete information is not available for these subjects. The data set is thus an assemblage of times to the event in question and times after which no more information on the individual is available. Survival analysis methods are the only techniques capable of handling censored observations without treating them as missing data. They also make no assumption regarding normal distribution of time to event data. Descriptive methods for exploring survival times in a sample include life table and Kaplan-Meier techniques as well as various kinds of distribution fitting as advanced modeling techniques. The Kaplan-Meier cumulative survival probability over time plot has become the signature plot for biomedical survival analysis. Several techniques are available for comparing the survival experience in two or more groups - the log-rank test is popularly used. This test can also be used to produce an odds ratio as an estimate of risk of the event in the test group; this is called hazard ratio (HR). Limitations of the traditional log-rank test have led to various modifications and enhancements. Finally, survival analysis offers different regression models for estimating the impact of multiple predictors on survival. Cox's proportional hazard model is the most general of the regression methods that allows the hazard function to be modeled on a set of explanatory variables without making restrictive assumptions concerning the nature or shape of the underlying survival distribution. It can accommodate any number of covariates, whether they are categorical or continuous. Like the adjusted odds ratios in logistic regression, this multivariate technique produces adjusted HRs for individual factors that may modify survival.

摘要

生存分析关注“事件发生时间”数据。传统上,它将癌症死亡视为所讨论的事件,但它可以处理在一个时间框架内发生的任何事件,而且该事件不一定总是负面的。当一项研究的结果是事件发生时间时,通常不可能等到所讨论的事件发生在所有受试者身上,例如,直到所有人都死亡。此外,受试者可能会提前退出研究。这种情况导致了所谓的删失观测值,因为无法获得这些受试者的完整信息。因此,数据集是所讨论事件的发生时间以及之后无法再获得个体更多信息的时间的集合。生存分析方法是唯一能够处理删失观测值而不将其视为缺失数据的技术。它们也不对事件发生时间数据的正态分布做任何假设。用于探索样本中生存时间的描述性方法包括生命表和 Kaplan-Meier 技术以及作为高级建模技术的各种分布拟合。 Kaplan-Meier 随时间变化的累积生存概率图已成为生物医学生存分析的标志性图表。有几种技术可用于比较两组或多组的生存经历——常用的是对数秩检验。该检验还可用于生成比值比,作为测试组中事件风险的估计值;这称为风险比(HR)。传统对数秩检验的局限性导致了各种改进和增强。最后,生存分析提供了不同的回归模型,用于估计多个预测因素对生存的影响。Cox 比例风险模型是最通用的回归方法,它允许在一组解释变量上对风险函数进行建模,而无需对潜在生存分布的性质或形状做出限制性假设。它可以容纳任意数量的协变量,无论它们是分类变量还是连续变量。与逻辑回归中的调整后比值比一样,这种多变量技术会为可能影响生存的个体因素生成调整后的 HR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125c/5448258/b0b2c97216fa/IJD-62-251-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125c/5448258/b57e7b226ee3/IJD-62-251-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125c/5448258/ffc98ce364fa/IJD-62-251-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125c/5448258/b0b2c97216fa/IJD-62-251-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125c/5448258/b57e7b226ee3/IJD-62-251-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125c/5448258/ffc98ce364fa/IJD-62-251-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125c/5448258/b0b2c97216fa/IJD-62-251-g005.jpg

相似文献

1
Biostatistics Series Module 9: Survival Analysis.生物统计学系列模块9:生存分析。
Indian J Dermatol. 2017 May-Jun;62(3):251-257. doi: 10.4103/ijd.IJD_201_17.
2
Survival analysis: A primer for the clinician scientists.生存分析:临床科学家入门指南。
Indian J Gastroenterol. 2021 Oct;40(5):541-549. doi: 10.1007/s12664-021-01232-1. Epub 2022 Jan 10.
3
Statistical primer: basics of survival analysis for the cardiothoracic surgeon.统计学基础:心胸外科医生生存分析基础
Interact Cardiovasc Thorac Surg. 2018 Jul 1;27(1):1-4. doi: 10.1093/icvts/ivy010.
4
Regression models for the restricted residual mean life for right-censored and left-truncated data.用于右删失和左截断数据的受限剩余平均寿命的回归模型。
Stat Med. 2017 May 20;36(11):1803-1822. doi: 10.1002/sim.7222. Epub 2017 Jan 20.
5
Sex differences in 30-day and 5-year outcomes after endovascular repair of abdominal aortic aneurysms in the EUROSTAR study.在 EUROSTAR 研究中,血管内修复腹主动脉瘤后 30 天和 5 年结局的性别差异。
J Vasc Surg. 2013 Jul;58(1):42-9.e1. doi: 10.1016/j.jvs.2013.01.028. Epub 2013 May 3.
6
Survival analysis and regression models.生存分析与回归模型。
J Nucl Cardiol. 2014 Aug;21(4):686-94. doi: 10.1007/s12350-014-9908-2. Epub 2014 May 9.
7
Kaplan-Meier curves for survivor causal effects with time-to-event outcomes.生存因果效应的 Kaplan-Meier 曲线与事件时间结局。
Clin Trials. 2013 Aug;10(4):515-21. doi: 10.1177/1740774513483601. Epub 2013 Apr 22.
8
A win ratio approach for comparing crossing survival curves in clinical trials.一种用于比较临床试验中交叉生存曲线的赢率比方法。
J Biopharm Stat. 2023 Jul 4;33(4):488-501. doi: 10.1080/10543406.2023.2170393. Epub 2023 Feb 7.
9
Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.马来西亚一家三级医院结直肠癌患者的生存率及生存预测因素
BMC Cancer. 2017 May 18;17(1):339. doi: 10.1186/s12885-017-3336-z.
10
Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point.在具有事件发生时间终点的优效性试验中,受限平均生存时间与风险比的比较。
Pharm Stat. 2018 May;17(3):202-213. doi: 10.1002/pst.1846. Epub 2017 Dec 28.

引用本文的文献

1
Swallowing Disorders, Survival and Functionality in Adults with Advanced Cancer Outside the Head and Neck and Upper Gastrointestinal Tract in Outpatient Palliative Care Setting: A Prospective Cohort Study.门诊姑息治疗环境中头颈部及上消化道以外晚期癌症成人患者的吞咽障碍、生存率和功能:一项前瞻性队列研究
Dysphagia. 2025 Sep 13. doi: 10.1007/s00455-025-10876-6.
2
Nomogram predicting overall survival in hospitalized cervical cancer patients in Mato Grosso, Brazil.巴西马托格罗索州住院宫颈癌患者总生存预测列线图
Discov Oncol. 2025 Jul 11;16(1):1312. doi: 10.1007/s12672-025-02380-y.
3
Survival analysis for cardiothoracic surgeons: part 6-interpreting time-to-event data.

本文引用的文献

1
Survival analysis part IV: further concepts and methods in survival analysis.生存分析第四部分:生存分析中的进一步概念与方法。
Br J Cancer. 2003 Sep 1;89(5):781-6. doi: 10.1038/sj.bjc.6601117.
2
Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.生存分析第三部分:多变量数据分析——选择模型并评估其充分性和拟合优度。
Br J Cancer. 2003 Aug 18;89(4):605-11. doi: 10.1038/sj.bjc.6601120.
3
Survival analysis part II: multivariate data analysis--an introduction to concepts and methods.
心胸外科医生的生存分析:第6部分 - 解读事件发生时间数据。
Indian J Thorac Cardiovasc Surg. 2025 May;41(5):629-644. doi: 10.1007/s12055-025-01911-0. Epub 2025 Mar 8.
4
Nomogram model for predicting the long-term prognosis of cervical cancer patients: a population-based study in Mato Grosso, Brazil.预测宫颈癌患者长期预后的列线图模型:巴西马托格罗索州的一项基于人群的研究
BMC Cancer. 2025 Apr 14;25(1):684. doi: 10.1186/s12885-025-14056-5.
5
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis.女性高密度脂蛋白胆固醇水平低和男性高甘油三酯血症:无脂肪变性个体中代谢相关脂肪性肝病发病的预测因素。
J Gastroenterol. 2025 Mar 18. doi: 10.1007/s00535-025-02242-y.
6
Treatment patterns and outcomes in patients with non-small cell lung cancer.非小细胞肺癌患者的治疗模式与治疗结果
Heliyon. 2024 Nov 5;10(22):e40147. doi: 10.1016/j.heliyon.2024.e40147. eCollection 2024 Nov 30.
7
Fecal tryptophan metabolite profiling in newborns in relation to microbiota and antibiotic treatment.新生儿粪便色氨酸代谢产物谱与微生物群和抗生素治疗的关系。
Appl Microbiol Biotechnol. 2024 Nov 5;108(1):504. doi: 10.1007/s00253-024-13339-4.
8
Time to death from cervical cancer and its predictors in hospitalized patients: a survival approach study in Mato Grosso, Brazil.因宫颈癌死亡的时间及其在住院患者中的预测因素:巴西马托格罗索州的一项生存方法研究。
World J Surg Oncol. 2024 Oct 9;22(1):269. doi: 10.1186/s12957-024-03518-y.
9
Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification.2022年世界卫生组织分类对嗜酸细胞性和滤泡性甲状腺癌重新分类的影响。
J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1343-e1350. doi: 10.1210/clinem/dgae581.
10
Genetic variants in as risk factors for mortality in patients unrelated but not associated with families with severe COVID-19.与严重 COVID-19 家庭无亲缘关系的患者中,[相关基因名称]的基因变异作为死亡风险因素,但无关联。 (你提供的原文“in as”表述有误,推测应该是某个基因名称,这里按照纠正后的理解翻译,若有误请根据正确原文调整)
Heliyon. 2024 Apr 9;10(8):e29493. doi: 10.1016/j.heliyon.2024.e29493. eCollection 2024 Apr 30.
生存分析第二部分:多变量数据分析——概念与方法介绍
Br J Cancer. 2003 Aug 4;89(3):431-6. doi: 10.1038/sj.bjc.6601119.
4
Survival analysis part I: basic concepts and first analyses.生存分析第一部分:基本概念与初步分析。
Br J Cancer. 2003 Jul 21;89(2):232-8. doi: 10.1038/sj.bjc.6601118.